
Rakesh Jhunjhunwala has exited MCX, after trimming his stakes in at least four firms — Lupin, Fortis Healthcare, The Mandhana…
Rakesh Jhunjhunwala has cut a stake in a healthcare firm Fortis Healthcare to 4.23 per cent
Rakesh Jhunjhunwala has trimmed stake in pharma major Lupin to below one per cent.
Ami Organics is scheduled to make its stock market debut on Tuesday, 14 September, after receiving over 64 times subscription…
Lupin share price fell nearly 2 per cent to Rs 958.70 apiece in intraday deals, following the April-June quarter earnings…
The chart pattern suggests that if Nifty crosses and sustains above 15950 level it would witness buying which would lead…
On Wednesday 15900/15930 (53000/53100) would be major hurdles and support would be at 15730/52500 and 15700/52400 levels.
Rakesh Jhunjhunwala-owned Lupin share price surged as high as 4.7 per cent to Rs 1,266.35 apiece in intraday deals on…
The chart pattern suggests that if Bank Nifty crosses and sustains above 33000 level it would witness buying which would…
Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening…
The company said its board has recommended a dividend of Rs 6.5 per equity share of the face value of…
Indian share market benchmarks BSE Sensex and Nifty 50 have been witnessing volatility amid the second COVID-19 wave.
February 2021 proved to be a roller coaster ride for the Nifty 50 index, where the first trading day of…
According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.
Federal Bank, CEAT, Heidelbergcement India, Lupin, TVS Motor, IIFL Finance, Muthoot Capital Services, Radico Khaitan, Rain Industries, Tata Steel Long…
Lupin Limited shares plunged nearly 8 per cent in early trade on Friday despite the pharma major reported 47.54 per…
In the past one year, share price of Lupin tanked 25.21 per cent to Rs 1495.10 till March 28, whereas…
Lupin shares soared around 8 per cent in the morning trade on Thursday on reports that the company get approval…